openPR Logo
Press release

Global Biologics Outsourcing Market Will Reach USD 52,846 Million By 2027

01-23-2020 12:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Facts & Factors

Biologics Outsourcing Market

Biologics Outsourcing Market

Facts and Factors Market Research has published a new report titled “Biologics Outsourcing Market By Product (Antibody, Vaccines, Recombinant Protein, and Others), By Type (Instruments and Kits & Reagents), By Source (Mammalian, Microbial, and Others), and By Applications (Vaccine & Therapeutics Development, Stem Cell Research, Blood & Blood-Related Products Testing, Tissue & Tissue Related Products Testing, and Cellular & Gene Therapy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027”. According to the report, the global Biologics Outsourcing market is predicted to be valued at approximately USD 11,668 million in 2018 and is expected to reach a value of around USD 52,846 million by 2027, at a CAGR of around 18.2% between 2019 and 2027.

Biologics are medicines that are derived from natural sources. They are the drugs that vary from chemically synthesized ones including aspirin and antacids. Precisely, the products are extracted from antibodies, microorganisms, and cells. Biologics are outsourced as it can effectively treat rheumatoid arthritis, kidney failure, high cholesterol levels, Crohn's disorder, and asthma.

Request Free Sample Copy of Research Report @ http://bit.ly/2RH0Lih

(May I send you a free copy? The sample of this report is readily available on request. Free report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology)

Rise in research activities pertaining to biologics will steer the market trends

A prominent increase in the research & development activities related to biologics is projected to spur the expansion of the biologics outsourcing industry during the forecast timeline. Apart from this, strong supply chain activities by the manufacturer are likely to attract the firms to offshore the biologics and this is likely to drive the business growth over the forecast timeline.

Furthermore, cost & time-saving benefits provided by biologics outsourcing activities will further propel the market expansion over the period from 2019 to 2027. Moreover, the biotech & pharma firms can save huge capital expenditure through biologics outsourcing and increase the invention and commercialization of the biologics over the forecast period, thereby prompting the market growth over the forecast timespan. Nevertheless, the high technical need for manufacturing biologics will impede business expansion.

Antibody to dominate the product segment over the forecast period

Inquire more about this report before purchase @ http://bit.ly/2RLIwYW

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

The segmental growth during the forecast timeline is owing to large-scale research activities carried out across the antibody engineering domain that will aid the monoclonal antibody-based product to remain a key biopharmaceuticals class over the coming years. Apart from this, the massive application of the antibodies for treating a large number of chronic ailments like asthma will further steer the segmental surge over the forecast timeline.

Vaccine & therapeutics development segment to record the highest CAGR during 2019-2027

The vaccine & therapeutics development segment is set to register the highest growth rate of more than 19% during the forecast timespan. The growth of the segment during the timeline from 2019 to 2027 is credited to the rise in the growing concerns related to the prevention of chronic ailments in people.

North America to account for the major revenue share of the overall market over the forecast timeframe

Request customized copy of report @ http://bit.ly/30MO6OT

(We customize your report according to your research need. Ask our sales team for report customization)

The regional market growth during the forecast timeline is attributed to the huge rate of biologic outsourcing and technological breakthroughs witnessed in the pharma and biotech business. Moreover, favorable government laws supporting the research pertaining to biologics along with the rapid transformation as well as paradigm shift witnessed in the field of biotechnology will prompt the regional market growth over the forecast period.

Some of the key participants in the business include Sino Biological Inc., Innovent Biologics, Inc., Syngene, GenScript, Boehringer Ingelheim GmbH, Abzena PLC, Adimab LLC, Albany Molecular Research Inc., Catalent, Inc., GL Biochem Corporation Ltd., JHL Biotech, Inc., GVK Biosciences Private Limited, Lonza, ProteoGenix, Selexis SA, Shanghai Medicilon Inc., Horizon Discovery Group plc, and The Jackson Laboratory.

This report segments the Biologics Outsourcing market as follows:

Biologics Outsourcing Market: By Product Analysis

Antibody
Monoclonal Antibody
Bi-specific Antibody
Antibody Drug Conjugates
Vaccines
Recombinant Protein
Others

Biologics Outsourcing Market: By Type Analysis

Instruments
Kits & Reagents

Biologics Outsourcing Market: By Source Analysis

Mammalian
Microbial
Others

Biologics Outsourcing Market: By Applications Analysis

Vaccine & Therapeutics Development
Stem Cell Research
Blood & Blood-Related Products Testing
Tissue & Tissue Related Products Testing
Cellular & Gene Therapy

Biologics Outsourcing Market: By Regional Segment Analysis

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa

Contact Us:

Facts & Factors

Global Headquarters

Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biologics Outsourcing Market Will Reach USD 52,846 Million By 2027 here

News-ID: 1906013 • Views:

More Releases from Facts & Factors

Trending: Military Vehicle Electrification Market Size & Share To Exceed USD 9.5 Billion by 2026 | Facts and Factors
Trending: Military Vehicle Electrification Market Size & Share To Exceed USD 9.5 …
The Military Vehicle Electrification Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. The report titled Military Vehicle Electrification Market is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. Request Access Full Report is Available @ https://www.fnfresearch.com/military-vehicle-electrification-market This covers market
Global AIOps (Artificial Intelligence for IT Operations) Market - Size, Share, Growth, Trends and Forecasts 2026
Global AIOps (Artificial Intelligence for IT Operations) Market - Size, Share, G …
The research report presents a strategic analysis of the AIOps (Artificial Intelligence for IT Operations) Market analysis through top players, size, share, key drivers, challenges, opportunities, competitive landscape, market attractiveness analysis, new product launches, technological innovations, and growth contributors. Further, the market attractiveness index is provided based on a five-forces analysis. View the Full Report with Table of Contents @ https://www.fnfresearch.com/artificial-intelligence-for-it-operations-market This report mainly focuses on the top players and their
Exceptional Growth in Global Quantum Dot Solar Cell Market Size, Share to Gain USD 2,319.8 Million by 2026: Facts & Factors
Exceptional Growth in Global Quantum Dot Solar Cell Market Size, Share to Gain U …
The Quantum Dot Solar Cell Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. Request Access Full Report is Available @ https://www.fnfresearch.com/quantum-dot-solar-cell-market The report titled "Quantum Dot Solar Cell Market" is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. This
Global Energy Meter Market Size, Share, Growth, Business Strategies and Forecast by 2026 | Exclusive Report by Facts & Factors
Global Energy Meter Market Size, Share, Growth, Business Strategies and Forecast …
The Energy Meter Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. Request Access Full Report is Available @ https://www.fnfresearch.com/energy-meter-market The report titled Energy Meter Market is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. This covers market demands, major

All 5 Releases


More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to